RWA
CCXI

River Wealth Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

River Wealth Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,800
Closed -$235K – 212
2020
Q4 		$235K Hold
3,800
– – 0.05% 192
2020
Q3 		$208K Hold
3,800
– – 0.05% 192
2020
Q2 		$219K Buy
+3,800
New +$207K 0.07% 173

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

River Wealth Advisors's CCXI Position: Q1 2021 in Review

River Wealth Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q1 2021, closing a stake of 3,800 shares — an estimated $235K sold.

River Wealth Advisors first reported a position in CCXI in Q2 2020 and held it in 3 quarters. The position peaked at $235K in Q4 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • River Wealth Advisors reported no remaining ChemoCentryx, Inc. position as of Q1 2021 after selling out during the quarter.
  • River Wealth Advisors sold 3,800 ChemoCentryx, Inc. shares in Q1 2021, an estimated $235K.
  • River Wealth Advisors first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 3 quarters.
  • River Wealth Advisors's ChemoCentryx, Inc. position peaked at $235K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on River Wealth Advisors's 13F filing for Q1 2021, filed 11 May 2021.